HIV Explainer
HIV is the human immunodeficiency virus, which attacks cells involved in the body’s immune defenses. It particularly affects CD4 cells, a type of white blood cell that helps coordinate responses to infection. Without treatment, the loss of these cells can leave someone vulnerable to serious infections and some cancers. HIV and AIDS are related terms with different meanings: HIV names the virus and infection, while AIDS describes its most advanced stage. An HIV diagnosis does not mean that a person has AIDS.
Treatment uses antiretroviral medicines to prevent the virus from multiplying effectively. Reducing the amount of HIV in the body helps protect the immune system and can support a long, healthy life. Treatment is generally ongoing, because suppressing the virus is different from eliminating the infection. The best regimen depends on medical circumstances, other medicines, and practical needs. Pills and some long-acting options are available, but the appropriate choice is made with a healthcare professional rather than from a general list of products.
Testing is the way to determine HIV status; symptoms and appearance cannot reliably answer that question. Different tests look for antibodies, a viral antigen, or viral genetic material. They can detect infection at different points after exposure. This delay is called the window period. A negative result taken too early may need follow-up, while a reactive screening result requires confirmation through the appropriate testing process. Understanding the type and timing of a test is essential to understanding what its result can establish.
People taking effective treatment who achieve and maintain an undetectable viral load do not transmit HIV to partners through sex. This is often expressed as Undetectable equals Untransmittable, or U=U. It refers to sustained viral suppression and sexual transmission, rather than a claim that the infection has been cured. Ongoing care connects treatment, laboratory monitoring, and support. Clear information about these distinctions helps people understand their health and reduces stigma that can otherwise interfere with testing and care.
HIV can be transmitted through certain body fluids, including blood and fluids involved in sexual contact. It can also pass during pregnancy, birth, or breastfeeding without appropriate preventive care. These routes involve specific kinds of exposure. HIV is not spread by hugging, shaking hands, sharing ordinary household objects, or being in the same room as someone who has the infection.
An opportunistic infection is one that occurs more readily or becomes more serious when immune defenses are weakened. Preventing such illness is one reason early diagnosis and effective treatment matter. The risk depends on the person's immune condition and care, not merely on the label HIV. Respectful communication recognizes both the seriousness of untreated infection and the substantial difference that treatment can make.
A test's window period is the interval between infection and reliable detection by that method. Blood-based laboratory testing and some rapid or self-tests have different windows. A testing service can explain which method was used and whether another test is needed. A result should therefore be interpreted together with the timing of the possible exposure, rather than treated as equally informative on every date.
Screening and confirmation are separate steps. A reactive self-test or screening test should lead to the recommended follow-up testing, not an assumption that the entire diagnostic process is complete. Conversely, a negative early result does not settle every question about a recent exposure. Knowing how results will be confirmed and communicated turns testing into a clear pathway with a defined next step.
Viral load measures the amount of HIV genetic material detected in blood and helps assess the response to treatment. The CD4 count provides information about immune-system status. These tests answer different questions, so a favorable change in one does not simply replace the other. Clinicians choose a monitoring schedule according to treatment response, stability, and the person's circumstances.
Regular review also addresses side effects, medicine interactions, and barriers to taking treatment as prescribed. Difficulty accessing medicines or keeping appointments is a practical care issue that deserves support. Changes to a regimen should be discussed with the care team. Maintaining an effective plan and checking its results are central to sustaining viral suppression, rather than relying on one reassuring laboratory report indefinitely.
Explore more "Explainers"
Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.